RORA and Parkinson disease: Furthermore, animal models of Parkinson’s disease (PD) with 6-hydroxydopamine (6-OHDA) have shown decreased BMAL1 and RORα persisted with levodopa treatment, suggesting that long-term levodopa treatment may impair circadian rhythm function and potentially lead to cognitive dysfunction [110].